These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
366 related articles for article (PubMed ID: 37598126)
21. OVOL2 links stemness and metastasis via fine-tuning epithelial-mesenchymal transition in nasopharyngeal carcinoma. Qi XK; Han HQ; Zhang HJ; Xu M; Li L; Chen L; Xiang T; Feng QS; Kang T; Qian CN; Cai MY; Tao Q; Zeng YX; Feng L Theranostics; 2018; 8(8):2202-2216. PubMed ID: 29721073 [No Abstract] [Full Text] [Related]
22. Ferroptosis Inducers for Prostate Cancer Therapy. Zaffaroni N; Beretta GL Curr Med Chem; 2022; 29(24):4185-4201. PubMed ID: 35021966 [TBL] [Abstract][Full Text] [Related]
23. Proteomics analysis reveals the role of ubiquitin specific protease (USP47) in Epithelial to Mesenchymal Transition (EMT) induced by TGFβ2 in breast cells. Silvestrini VC; Thomé CH; Albuquerque D; de Souza Palma C; Ferreira GA; Lanfredi GP; Masson AP; Delsin LEA; Ferreira FU; de Souza FC; de Godoy LMF; Aquino A; Carrilho E; Panepucci RA; Covas DT; Faça VM J Proteomics; 2020 May; 219():103734. PubMed ID: 32201364 [TBL] [Abstract][Full Text] [Related]
24. Targeting GPX4 in human cancer: Implications of ferroptosis induction for tackling cancer resilience. Lee J; Roh JL Cancer Lett; 2023 Apr; 559():216119. PubMed ID: 36893895 [TBL] [Abstract][Full Text] [Related]
25. Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway. Viswanathan VS; Ryan MJ; Dhruv HD; Gill S; Eichhoff OM; Seashore-Ludlow B; Kaffenberger SD; Eaton JK; Shimada K; Aguirre AJ; Viswanathan SR; Chattopadhyay S; Tamayo P; Yang WS; Rees MG; Chen S; Boskovic ZV; Javaid S; Huang C; Wu X; Tseng YY; Roider EM; Gao D; Cleary JM; Wolpin BM; Mesirov JP; Haber DA; Engelman JA; Boehm JS; Kotz JD; Hon CS; Chen Y; Hahn WC; Levesque MP; Doench JG; Berens ME; Shamji AF; Clemons PA; Stockwell BR; Schreiber SL Nature; 2017 Jul; 547(7664):453-457. PubMed ID: 28678785 [TBL] [Abstract][Full Text] [Related]
26. Role of epithelial-mesenchymal transition in gastric cancer initiation and progression. Peng Z; Wang CX; Fang EH; Wang GB; Tong Q World J Gastroenterol; 2014 May; 20(18):5403-10. PubMed ID: 24833870 [TBL] [Abstract][Full Text] [Related]
27. The therapeutic potential of targeting the epithelial-mesenchymal transition in cancer. Ginnebaugh KR; Ahmad A; Sarkar FH Expert Opin Ther Targets; 2014 Jul; 18(7):731-45. PubMed ID: 24758643 [TBL] [Abstract][Full Text] [Related]
28. Epithelial Mesenchymal Transition in Tumor Metastasis. Mittal V Annu Rev Pathol; 2018 Jan; 13():395-412. PubMed ID: 29414248 [TBL] [Abstract][Full Text] [Related]
29. Classical epithelial-mesenchymal transition (EMT) and alternative cell death process-driven blebbishield metastatic-witch (BMW) pathways to cancer metastasis. Jinesh GG; Brohl AS Signal Transduct Target Ther; 2022 Aug; 7(1):296. PubMed ID: 35999218 [TBL] [Abstract][Full Text] [Related]
30. Evodiamine Exhibits Anti-Bladder Cancer Activity by Suppression of Glutathione Peroxidase 4 and Induction of Ferroptosis. Hu CY; Wu HT; Shan YS; Wang CT; Shieh GS; Wu CL; Ou HY Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37046995 [TBL] [Abstract][Full Text] [Related]
31. Role of Ferroptosis in Regulating the Epithelial-Mesenchymal Transition in Pulmonary Fibrosis. Ling H; Xiao H; Luo T; Lin H; Deng J Biomedicines; 2023 Jan; 11(1):. PubMed ID: 36672671 [TBL] [Abstract][Full Text] [Related]
32. Ferroptosis model system by the re-expression of BACH1. Irikura R; Nishizawa H; Nakajima K; Yamanaka M; Chen G; Tanaka K; Onodera M; Matsumoto M; Igarashi K J Biochem; 2023 Jul; 174(3):239-252. PubMed ID: 37094356 [TBL] [Abstract][Full Text] [Related]
33. Human umbilical cord mesenchymal stem cells derived exosome shuttling mir-129-5p attenuates inflammatory bowel disease by inhibiting ferroptosis. Wei Z; Hang S; Wiredu Ocansey DK; Zhang Z; Wang B; Zhang X; Mao F J Nanobiotechnology; 2023 Jun; 21(1):188. PubMed ID: 37303049 [TBL] [Abstract][Full Text] [Related]
34. Narrower insight to SIRT1 role in cancer: A potential therapeutic target to control epithelial-mesenchymal transition in cancer cells. Choupani J; Mansoori Derakhshan S; Bayat S; Alivand MR; Shekari Khaniani M J Cell Physiol; 2018 Jun; 233(6):4443-4457. PubMed ID: 29194618 [TBL] [Abstract][Full Text] [Related]
35. Endoplasmic reticulum stress-triggered ferroptosis via the XBP1-Hrd1-Nrf2 pathway induces EMT progression in diabetic nephropathy. Liu Z; Nan P; Gong Y; Tian L; Zheng Y; Wu Z Biomed Pharmacother; 2023 Aug; 164():114897. PubMed ID: 37224754 [TBL] [Abstract][Full Text] [Related]
36. Anti-Cancer Potential of Phytochemicals: The Regulation of the Epithelial-Mesenchymal Transition. Liu S; Li L; Ren D Molecules; 2023 Jun; 28(13):. PubMed ID: 37446730 [TBL] [Abstract][Full Text] [Related]
37. Epithelial-Mesenchymal Transition (EMT) as a Therapeutic Target. Jonckheere S; Adams J; De Groote D; Campbell K; Berx G; Goossens S Cells Tissues Organs; 2022; 211(2):157-182. PubMed ID: 33401271 [TBL] [Abstract][Full Text] [Related]
38. NF- Zhou Y; Qian W; Li X; Wei W Oxid Med Cell Longev; 2023; 2023():7098313. PubMed ID: 36699318 [TBL] [Abstract][Full Text] [Related]
39. Ferroptosis: machinery and regulation. Chen X; Li J; Kang R; Klionsky DJ; Tang D Autophagy; 2021 Sep; 17(9):2054-2081. PubMed ID: 32804006 [TBL] [Abstract][Full Text] [Related]
40. Proteomic analysis of ovarian cancer cells during epithelial-mesenchymal transition (EMT) induced by epidermal growth factor (EGF) reveals mechanisms of cell cycle control. Grassi ML; Palma CS; Thomé CH; Lanfredi GP; Poersch A; Faça VM J Proteomics; 2017 Jan; 151():2-11. PubMed ID: 27394697 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]